Okan Ekinci, Global Director of Cardiology at Siemens Healthcare, is convinced that, ultimately, ultrasound will remain the ‘entry level’ imaging procedure for patients. European Hospital met up with him at this year’s ESC congress to hear his thoughts on the potential of ultrasound – and particularly its fusion with other imaging modalities.
The Task Force Health Care (TFHC) was initiated in 1996 by the private sector; the Dutch government acts as a partner.
Until recently, hospitals were constructed the way they had been built through centuries. Today, however, hospital design is shifting towards patient logistics, opening up very new perspectives.
The USA’s healthcare system has awakened to the fact that electronically stored health patient data can save billions of dollars. Predictive analysis of ‘Big Data’ is a hot topic.The USA’s healthcare system has awakened to the fact that electronically stored health patient data can save billions of dollars. Predictive analysis of ‘Big Data’ is a hot topic.
A Technology Strategy and Roadmap to plot the course of IT within the National Health Service (NHS) over the next few years was unveiled recently by NHS England.
Unisyn, a division of GE Healthcare that provides a multi-brand ultrasound probe repair solutions to biomedical and clinical engineers, is expanding product sales and services into Europe.
Despite on-going negotiations with the Government, the Union for Medical Biologists has received a nasty surprise that threatens up to 8,000 jobs in the sector.
In the country’s first scientific study to correlate the demographic changes and frequency of tumorous diseases, demographic changes have led scientists to forecast a significant increase in the number of cancerous diseases in coming years.
The highly-anticipated and positive results from the IN-TIME study of home monitoring technology were recently presented in a hotline session at this year’s European Society of Cardiology (ESC) congress by coordinating investigator Professor Gerhard Hindricks MD, from the Heart Centre, University of Leipzig, Germany.
Royal Philips Electronics and Sectra today announced an agreement to extend the term of their existing PACS support partnership agreement. This agreement allows Philips to provide continued support for Sectra PACS installations through 2020, and can be extended on a yearly basis thereafter.
Over the last decade, the biggest driver of the high health care costs in the United States has been neither the aging of the population nor the large numbers of tests and treatments being prescribed.
Crowds of hospital delegates flocking in to Xiamen on the first day of CMEF had already suggested that the event will be welcoming more than the roughly 60,000 delegates expected to participate
Through the miracle of modern-day ultrasound, we are able to see – in three dimensions and in real time – the functioning of arteries, veins and the many sophisticated structures of the heart. While most think of ultrasound technology as it relates to grinning parents getting a first glance of their baby in the womb, cardiovascular care is being revolutionised by advances in ultrasound…
Over the past decade, laboratory medicine developed rapid, accurate tests that help in diagnoses, prognoses, treatments – and the overall theragnostics; but is it economical? This November, at the Journées Internationales de Biologie (JIB) meeting in Paris, that question will shape the medical economics session Medical biology: a key factor in the healthcare effectiveness, organised by the in…
Already popular in private healthcare, increasing global acceptance of refurbished equipment encourages uptake in the public sector.
This year a further one in six of England’s hospitals started to offer patients the choice of ‘self-funding’ for treatments and services that are subject to restrictions or long NHS waiting times. These include IVF treatment, cataract surgery, varicose veins, carpal tunnel syndrome therapy and hernia repair.
The current financial crisis is having a major impact on European economies, especially that of Spain. Past evidence suggests that adverse macro- economic conditions exacerbate mental illness, but evidence from the current crisis is limited.
United Kingdom – The Royal College of General Practitioners, Royal College of Radiologists and the Society and College of Radiographers have worked together on recommendations that outline improvements for patients by ensuring that timely and appropriate medical imaging services are provided to them and their referring doctors.
Samsung BioLogics today announced that Samsung BioLogics and F. Hoffmann-La Roche have entered into a long term strategic manufacturing agreement under which Samsung will manufacture Roche's proprietary commercial biologic medicines at its two manufacturing facilities in Incheon, South Korea, of which one is currently under construction.
In intensive care units (ICUs) little can be automated to relieve staff pressures – with the exception of point of care testing (POCT)
Nat Whitney, President of Whitney Research, sums up the ups and downs of the international IVD market and reports on a fitting finale for 17 years of dedicated service
Eucomed, the European medical technology industry association, expresses disappointment and strong concern at the outcome of a vote in the European Parliament’s Committee for Environment, Public Health and Food Safety (ENVI).
There is a global shortage of doctors that is getting worse every year. With the demographic shift in many countries from a predominantly young to an increasing aging population, a steep increase in chronic disease is occurring.
Snibe, the Shenzhen New Industries Biomedical Engineering Company Ltd., is a leading Chinese biomedical technology company dedicated to developing and manufacturing clinical laboratory equipment and in vitro reagents. Founded 18 years ago and a growing force in the Chinese market, the firm is based in Shenzhen, China’s fourth largest city, situated in Guangdong Province.
The results of a survey amongst medical device companies in Europe about the financial impact of the upcoming changes in the European medical device regulation show a significant increase in costs for bringing new devices to patients.
